News | May 26, 2008

Treating Cancer with Hyperthermia Hot Topic in Europe

May 27, 2008 - BSD Medical Corp. said recently that several recent events have occurred in Europe that highlight the use of hyperthermia therapy in treating cancer.

Following the International Congress on Hyperthermic Oncology (ICHO) conducted last month in Munich, Germany, the joint annual meeting of the DEGRO Deutsche Gesellschaft fur Radio-Onkologie (German Society of Radiation Oncology) and OGRO Osterreichische Gesellschaft fur Radio-Onkologie (Austrian Society of Radiation Oncology) held in Vienna, Austria, also addressed hyperthermia therapy. In addition, there have been several new articles on hyperthermia therapy recently published.

“Hyperthermia as an Integral Component of Multimodality Therapy” was the theme of the Symposium on Hyperthermia Therapy at the joint annual meeting (DEGRO and OGRO) recently concluded in Vienna, Austria. The symposium was jointly chaired by Rolf Sauer, M.D., chairman of the Comprehensive Tumor Center of UMS Erlangen, and Frederik Wenz, M.D., chairman of Radiation-Oncology of the University Medical School at Mannheim-Heidelberg, Germany. Keynote speakers included prominent physicians and professors that routinely incorporate hyperthermia into their treatment of cancer, including Ellen Jones, M.D. (UMS Duke University, U.S.), Martine Franckena, M.D. (UMS Erasmus Rotterdam, Netherlands), Johanna Gellermann, M.D. (UMS Charite Berlin, Germany), Oliver Ott, M.D. and Udo Gaipl, Ph.D. (UMS Erlangen, Germany) and Frederik Wenz, M.D. (UMS Mannheim-Heidelberg, Germany). Dr. Gaipl strongly emphasized the potential of hyperthermia as the most potent radiation sensitizer available in cancer treatment.

In a recent publication of PHARMAZEUTISCHE ZEITUNG (PHARMACEUTICAL NEWS), Claudia Borchard Cloth described hyperthermia as “high tech warmth to fight against cancer.” She detailed how both deep and superficial hyperthermia effectively improves outcomes for conventional treatment methods like chemotherapy, radiation therapy and surgery. She explained that “tumor cells are particularly heat sensitive … temperatures over 40 degrees Celsius make them susceptible to attack from natural defense processes and radiation therapy.” She continues by stating “a number of new regional hyperthermia studies document survival data that is three times higher than standard therapy alone.”

In the “Technology and Medicine” section of the March issue of Hospital UMSCHAU, Claus Schwing addressed the benefits of hyperthermia therapy in an article titled “Hyperthermia – The Fourth Column of Cancer Treatment.” He quoted Dr. Ruediger Wessalowski from Dusseldorf as stating: “We are seeing amazing success with hyperthermia used in combination with other procedures.” He describes the alarming worldwide growth of cancer. In the past three years, the number of cancer patients in Europe increased from 2.9 million to 3.2 million. In 2009 Schwing estimates that 1.7 million Europeans will die of cancer.

For more information: www.BSDMedical.com

Related Content

MR-HIFU, ThermoDox, combination therapy, recurrent childhood tumors, Celsion, Children's National Health System, Phase I clinical study
News | Oncology Related Products | December 19, 2016
December 19, 2016 — Children’s National Health System and Celsion Corp.
News | Clinical Decision Support | October 27, 2016
October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use
contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016
September 12, 2016 — Tiny microbubbles are being used to more effectively...
cardio-oncology, echo strain assessment, echoinsight, epsilon

Epsilon's EchoInsight software helps analyze cardiac function by evaluating wall motion strain. 

Feature | Cardio-oncology | May 13, 2016 | Dave Fornell
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat
Carestream, Clinical Collaboration Platform, Fox Valley Hematology & Oncology
News | Enterprise Imaging | April 20, 2016
Fox Valley Hematology & Oncology (Appleton, Wis.) implemented Carestream’s Vue for Clinical Collaboration Platform...
cancer immunotherapy, development, Axel Hoos, Nature Reviews, imaging
News | Oncology Related Products | March 31, 2016
In a paper published in Nature Reviews last week, Axel Hoos, M.D., Ph.D., laid out the current immunotherapy...
Pyrexar, buy back outside ownership, Person Medical, BSD-2000 Hyperthermia System

BSD-2000 image courtesy of Pyrexar Medical

News | Oncology Related Products | March 15, 2016
Pyrexar announced it has purchased back outside ownership from Person Medical (formerly BSD Medical), concluding a...
BTG, LC Bead LUMI, radiopaque embolic bead, Philips Healthcare, Live Image Guidance, liver cancer
News | Interventional Radiology | February 09, 2016
BTG plc and Royal Philips announced a significant milestone in their collaboration with the treatment of the first...
Overlay Init